22 results on '"Tang, Jinhai"'
Search Results
2. Overcoming chemoresistance in triple-negative breast cancer (TNBC): Targeting PD-L1 stability and ferroptosis through integrated lipid metabolism and immune modulation.
3. A multiple center, open-label, single-arm, phase II clinical trial of MRG002, an HER2-targeted antibody-drug conjugate, in patients with HER2-low expressing advanced or metastatic breast cancer.
4. Gamma-interferon inducible lysosomal thiolreductase (GILT) effect on breast tumor microenvironment through regulating CXCR6/CXCL16 axis.
5. SGK1 regulated apoptosis in invasive breast carcinoma.
6. A nomogram to predict the value of mammary adipose index (MAI) for prediction of response to neoadjuvant chemotherapy in breast cancer patients.
7. Extracellular circular RNAs to promote the growth and metastasis of triple-negative breast cancer through remodeling the tumor immune microenvironment.
8. TrxR1 to promote adriamycin resistance in MCF-7 breast cancer cells by upregulating both gene expression level and enzyme activity: Reversed by shikonin.
9. Exosomal circular RNAs derived from serum: Promising biomarkers for therapeutic targets and prognosis of triple-negative breast cancer (TNBC).
10. Phase I study to assess the safety, tolerability, pharmacokinetics/pharmacodynamics and preliminary efficacy of SC10914 in patients with advanced solid tumors.
11. The role of circCNIH4 in the adipocyte's effects on metastasis of breast cancer cells.
12. RelB silencing to reverse tamoxifen resistance by regulating GPx4 and ferroptosis in breast cancer.
13. IL-6 influences PD-L1 expression in monocytes and macrophages by effecting protein tyrosine phosphatase receptor type O expression in-human breast cancer.
14. Identification of CCN1 transferred by extracellular vesicles derived from breast cancer cells responsible for doxorubicin-resistance.
15. Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial.
16. Circulating exosomal microRNA profiling to depict mechanisms of chemotherapy resistance among triple negative breast cancer.
17. Concordance, decision impact and guidelines adherence using artificial intelligence in high-risk breast cancer.
18. Contribution of microRNA-3646 to docetaxel resistance in human breast cancer cells by GSK-3β/β-catenin signaling pathway.
19. Pan-cancer analysis to identify molecules interacting with CasL-Like 2 to promote angiogenesis via mTOR/HIF1A/VEGFA pathway in hypoxia tumor environment.
20. Lactate-induced lactylation circularly regulates glucose metabolism enzymes in breast cancer.
21. The mechanism of exosome delivered circ-PDE7B promoting liver metastasis of breast cancer.
22. Exosome-based delivery of microRNAs to confer adriamycin-resistance to sensitive cells through modulating the immune- and metabolism-related gene PTEN in HER2-negative breast cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.